News Image

Looking for growth without the hefty price tag? Consider NASDAQ:BLBD.

By Mill Chart

Last update: Apr 16, 2024

Consider BLUE BIRD CORP (NASDAQ:BLBD) as an affordable growth stock, identified by our stock screening tool. NASDAQ:BLBD is showcasing impressive growth figures and is well-positioned in terms of profitability, solvency, and liquidity. Moreover, it seems to be priced reasonably. Let's dive deeper into the analysis.

A Closer Look at Growth for NASDAQ:BLBD

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NASDAQ:BLBD has earned a 7 for growth:

  • The Earnings Per Share has grown by an impressive 267.65% over the past year.
  • The Revenue has grown by 33.90% in the past year. This is a very strong growth!
  • BLBD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.28% yearly.
  • BLBD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.53% yearly.
  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

A Closer Look at Valuation for NASDAQ:BLBD

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NASDAQ:BLBD has received a 7 out of 10:

  • 73.64% of the companies in the same industry are more expensive than BLBD, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.05. BLBD is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio, BLBD is valued cheaper than 81.40% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.53. BLBD is valued slightly cheaper when compared to this.
  • BLBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLBD is cheaper than 72.87% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BLBD is valued cheaper than 86.05% of the companies in the same industry.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BLBD's earnings are expected to grow with 50.28% in the coming years. This may justify a more expensive valuation.

Deciphering NASDAQ:BLBD's Health Rating

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:BLBD scores a 5 out of 10:

  • An Altman-Z score of 5.57 indicates that BLBD is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.57, BLBD is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
  • The Debt to FCF ratio of BLBD is 1.51, which is an excellent value as it means it would take BLBD, only 1.51 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.51, BLBD belongs to the best of the industry, outperforming 83.72% of the companies in the same industry.
  • Although BLBD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

Evaluating Profitability: NASDAQ:BLBD

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:BLBD was assigned a score of 5 for profitability:

  • BLBD's Return On Assets of 14.21% is amongst the best of the industry. BLBD outperforms 92.25% of its industry peers.
  • BLBD's Return On Equity of 81.07% is amongst the best of the industry. BLBD outperforms 99.22% of its industry peers.
  • BLBD's Return On Invested Capital of 26.72% is amongst the best of the industry. BLBD outperforms 98.45% of its industry peers.
  • In the last couple of years the Operating Margin of BLBD has grown nicely.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Check the latest full fundamental report of BLBD for a complete fundamental analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

BLUE BIRD CORP

NASDAQ:BLBD (4/29/2024, 3:53:27 PM)

After market: 34.52 0 (0%)

34.52

+0.55 (+1.62%)

BLBD News

News Imagean hour ago - InvestorPlace3 Obscure Stocks That Could Revolutionize Your Returns

Investors mostly pay close attention to popular stocks. But, there are also strong stocks with low trading volume available.

News Image5 days ago - Blue Bird CorporationBlue Bird to Report Fiscal 2024 Second Quarter Results on May 8, 2024
News Image12 days ago - ChartmillShould you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?

Why the growth investor may take a look at BLUE BIRD CORP (NASDAQ:BLBD).

News Image13 days ago - ChartmillLooking for growth without the hefty price tag? Consider NASDAQ:BLBD.

While growth is established for BLUE BIRD CORP (NASDAQ:BLBD), the stock's valuation remains reasonable.

News Image19 days ago - InvestorPlaceAhead of the Curve: 7 Stocks to Buy Before They Go Mainstream

Discover seven overlooked stocks to buy poised for 10X returns across diverse industries. Unlock their growth potential now.

News Imagea month ago - InvestorPlace7 EV Stocks That Could Be Multibaggers in the Making: March Edition

Discover EV stocks poised for explosive growth, tapping into cutting-edge technology and market dominance.

News Imagea month ago - InvestorPlace3 Promising Small-Cap Stocks Packing a Powerful Punch

Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.

News Image2 months ago - InvestorPlaceBeat Wall Street: 3 Stocks Flying Under the Radar

The market is full of many companies that most people haven’t even heard of. Add these stocks to your portfolio that fly under the radar.

News Image2 months ago - InvestorPlace7 Must-Buy Stocks for a Diversified High-Growth Portfolio

Explore how these high-growth portfolio stocks can drive substantial returns in IT, communication, industrials, and financials.

News Image2 months ago - NewsfileAdaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...

News Image2 months ago - InvestorPlaceWall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024

Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless.

News Image2 months ago - InvestorPlace3 Goliath Growth Stocks Poised for Takeoff in February

These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing.

BLBD Links
Follow us for more